- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04732754
Effect of Cocoa Supplementation and Aerobic Exercise on Pressure Parameters
Effect of Cocoa Supplementation and Aerobic Exercise on Central Pressure and Arterial Stiffness Parameters in Physically Inactive Middle-aged Individuals
This study evaluates the cocoa supplementation and aerobic exercise on central pressure and arterial stiffness parameters in physically inactive middle-aged individuals.
500mg capsules will be offered to all patients. Of these, half will offer the content of 500mg of cocoa per capsule or placebo capsules. The placebo will contain a pharmacologically inert substance (microcrystalline cellulose) of the same color. A half will start 50' aerobic training 3 times/week while the other half will continue without exercise.
Study Overview
Status
Conditions
Detailed Description
Cardiovascular diseases (CVDs) are the number one cause of death in the world: more people die annually from CVDs than from any other cause. The arterial hypertension is one of the main predictors of CVDs. The number of adults with high blood pressure increased from 594 million in 1975 to 1.13 billion in 2015( WHO, 2020).
Due to the great increase in Hypertension around the world, new technological ways of assessing pressure have been discussed in the clinical setting, not only peripheral, but also central.
In this sense, the applanation tonometry of different arteries (carotid and radial), the analysis of pulses by various algorithms and the ability to estimate the shape of the pulse wave in the descending aorta root has been gaining prominence.
Flavonoids are a group of polyphenol compounds found in plants. The possible benefits from these compounds are related to cardiovascular health through specific actions on the artery wall. Prospective studies have shown that flavonoids can improve arterial stiffness, measured by Pulse Wave Velocity (PWV).
Physical exercise can intensifies organic functioning in different systems oh human body, including the cardiovascular. Studies has shown that chronic adaptations of pshysical exercise can improve arterial stiffness and central blood pressure parameters.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Alexandre Lehnen, PhD
- Phone Number: 55 51 999768092
- Email: amlehnen@gmail.com
Study Contact Backup
- Name: Tainah Ortiz, M.Sc
- Phone Number: 55 51 999171990
- Email: tainahortiz05@gmail.com
Study Locations
-
-
Rio Grande Do Sul
-
Porto Alegre, Rio Grande Do Sul, Brazil, 90620001
- Instituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Cardiologia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Sedentary lifestyle (IPAQ- International Physical Activity Questionnaire);
- Eutrophic or overweight (BMI >18,5kg/m² and <30kg/m²).
Exclusion Criteria:
- Individuals with a feverish state and / or infectious disease;
- Individuals with diabetes mellitus or coronary artery disease;
- Individuals who have any recent cardiovascular events (last 3 months) or chronic renal failure; history of malignant diseases with life expectancy <2 years;
- Use of statins;
- Smokers (those who have never smoked or smoked less than 100 cigarettes (5 bags of 20 cigarettes) in their lifetime and for at least 5 years);
- Alcoholics (The WHO estabilish ad acceptable the consumption is up to 15 doses / week for men and 10 for women, with 1 dose equivalent to approximately 350 mL of beer, 150 mL of wine or 40 mL of a distilled drink, considering that each contains between 10 and 15 g of ethanol);
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
PLACEBO_COMPARATOR: Control Group (CG)
This group will receive placebo capsules to be consumed for 8 weeks daily and will not exercise;
|
Daily consumption of placebo capsules for 8 weeks
|
|
ACTIVE_COMPARATOR: Aerobic Exercise (AE)
This group will receive placebo capsules and will perform 3 sessions of physical exercise / week, 50 min / session, with moderate intensity of 50-70% of VO2peak for 8 weeks.
|
Daily consumption of placebo capsules and 3 sessions of physical exercise / week, 50 min / session, with moderate intensity of 50-70% of VO2peak for 8 weeks.
|
|
EXPERIMENTAL: Aerobic exercise + Theobroma cocoa (AETC)
This group will receive 500mg cocoa capsules to be consumed daily and will perform 3 sessions of physical exercise / week, 50 min / session, with moderate intensity of 50-70% VO2peak) for 8 weeks
|
Daily consumption of 500mg cocoa in capsules and 3 sessions of physical exercise / week, 50 min / session, with moderate intensity of 50-70% of VO2peak for 8 weeks.
|
|
EXPERIMENTAL: Theobroma cocoa (TC)
This group will receive 500mg cocoa capsules to be consumed daily for 8 weeks.
|
Daily consumption of 500mg cocoa in capsules for 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Arterial Stiffness by Pulse Wave Velocity
Time Frame: 8 weeks
|
The assessment of arterial stiffness will be carried out using the non-invasive method of PWV , which is obtained by dividing the carotid-femoral distance by the systolic wave travel time (in the unit of m / s) It will be checked by the Complior Analyzer equipment, with the volunteer in a supine position in an air-conditioned environment and controlled lighting in a LIC room, with the sensors placed over the right carotid and femoral arteries.
The distance between the two points is measured by an infantometer and the data of pressure, total body weight and distance between the points of the sensors in the carotid artery and in the femoral artery are entered in the software to calculate the PWV.
This analysis will be carried out before and after the intervention period.
|
8 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Tainah Ortiz, M.Sc, Instituto de Cardiologia
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- UP 5839.20
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sedentary Behavior
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSedentary Behavior | Sedentary TimeUnited States
-
Stanford UniversityActive, not recruiting
-
University of California, San DiegoCompleted
-
Cairo UniversityRecruitingSedentary BehaviorsEgypt
-
Istanbul Aydın UniversityCompletedSedentary Lifestyle | Functional CapacityTurkey (Türkiye)
-
Gazi UniversityCompletedSedentary | Athlete | Core Muscle EnduranceTurkey (Türkiye)
-
China-Japan Friendship HospitalNot yet recruitingSedentary Lifestyle | Behavioral Intervention
-
Sezer TaştanCompletedSedentary Lifestyle | Cardiorespiratory FitnessTurkey (Türkiye)
-
Recep Tayyip Erdogan UniversityCompletedPhysical Inactivity | Sedentary BehaviorsTurkey (Türkiye)
-
Research on Healthcare Performance Lab U1290RecruitingSedentary Behavior | Sedentary Time | Health Behavior | Health-Related Behavior | Physical InactivityFrance
Clinical Trials on Control Group (CG)
-
Universiti Putra MalaysiaNot yet recruitingCardiometabolic SyndromeMalaysia
-
Universidad de CórdobaUnknown
-
Fundación Pública Andaluza para la Investigación...University of MalagaUnknownDepression | Type 1 Diabetes MellitusSpain
-
Istanbul Arel UniversityCompletedShoulder Impingement Syndrome | Trigger Point PainTurkey
-
Novindiet ClinicTehran University of Medical Sciences; University of NottinghamCompletedObesity | OverweightIran, Islamic Republic of
-
Universidad de CórdobaUnknownOverweight and Obesity | Signs and Symptoms | Behavior, EatingSpain
-
Mieko Cláudia MiuraHospital do CoracaoCompleted
-
University of VirginiaRivanna Medical, LLCCompleted
-
Washington University School of MedicineSpinal Cord Injury/Disease Research ProgramCompleted
-
University of Sao PauloCompleted